Clorox (NYSE:CLX) Trading 4.6% Higher – Here’s What Happened

Shares of The Clorox Company (NYSE:CLX) rose 4.6% during trading on Friday . The stock traded as high as $93.50 and last traded at $93.7570. Approximately 1,421,862 shares traded hands during trading, a decline of 44% from the average daily volume of 2,553,910 shares. The stock had previously closed at $89.63.

Wall Street Analysts Forecast Growth

CLX has been the topic of several research reports. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. TD Cowen lifted their price target on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. BNP Paribas Exane decreased their price target on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 12th. Morgan Stanley cut their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Finally, Barclays cut their target price on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $103.40.

Clorox Price Performance

The stock has a market cap of $11.37 billion, a P/E ratio of 15.27, a PEG ratio of 0.46 and a beta of 0.56. The firm’s fifty day moving average price is $97.16 and its 200-day moving average price is $105.39. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts forecast that The Clorox Company will post 5.61 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.63% of the stock is currently owned by company insiders.

Institutional Trading of Clorox

Several large investors have recently added to or reduced their stakes in CLX. Center for Financial Planning Inc. bought a new stake in Clorox in the third quarter valued at $25,000. Vermillion & White Wealth Management Group LLC bought a new stake in Clorox in the third quarter valued at $25,000. Caitlin John LLC lifted its position in Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after buying an additional 253 shares during the period. Darwin Wealth Management LLC purchased a new position in Clorox during the second quarter valued at $29,000. Finally, Vision Financial Markets LLC lifted its position in Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after buying an additional 200 shares during the period. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.